Sub-Poissonian statistics of Rydberg-interacting dark-state polaritons

Interfacing light and matter at the quantum level is at the heart of modern atomic and optical physics and enables new quantum technologies involving the manipulation of single photons and atoms. A prototypical atom-light interface is electromagnetically induced transparency, in which quantum interference gives rise to hybrid states of photons and atoms called dark-state polaritons. We have observed individual dark-state polaritons as they propagate through an ultracold atomic gas involving Rydberg states. Strong long-range interactions between Rydberg atoms give rise to an effective interaction blockade for dark-state polaritons, which results in large optical nonlinearities and modified polariton number statistics. The observed statistical fluctuations drop well below the quantum noise limit indicating that photon correlations modified by the strong interactions have a significant back-action on the Rydberg atom statistics.Comment: 7 pages, 4 figure

A quantum trampoline for ultra-cold atoms

We have observed the interferometric suspension of a free-falling Bose-Einstein condensate periodically submitted to multiple-order diffraction by a vertical 1D standing wave. The various diffracted matter waves recombine coherently, resulting in high contrast interference in the number of atoms detected at constant height. For long suspension times, multiple-wave interference is revealed through a sharpening of the fringes. We use this scheme to measure the acceleration of gravity

Connecting Berezinskii-Kosterlitz-Thouless and BEC Phase Transitions by Tuning Interactions in a Trapped Gas.

We study the critical point for the emergence of coherence in a harmonically trapped two-dimensional Bose gas with tunable interactions. Over a wide range of interaction strengths we find excellent agreement with the classical-field predictions for the critical point of the Berezinskii-Kosterlitz-Thouless (BKT) superfluid transition. This allows us to quantitatively show, without any free parameters, that the interaction-driven BKT transition smoothly converges onto the purely quantum-statistical Bose-Einstein condensation transition in the limit of vanishing interactions.This work was supported by AFOSR, ARO, DARPA OLE, and EPSRC [Grant No. EP/K003615/1]. N. N. acknowledges support from Trinity College, Cambridge, R. P. S. from the Royal Society, and K. G. H. V. from DAAD.This is the author accepted manuscript. The final version is available from APS via http://dx.doi.org/10.1103/PhysRevLett.114.25530

Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection

Background: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndromes (ACS) afflicting predominantly younger to middle-aged women. Observational studies have reported a high prevalence of extracoronary vascular anomalies, especially fibromuscular dysplasia (FMD) and a low prevalence of coincidental cases of atherosclerosis. PHACTR1/EDN1 is a genetic risk locus for several vascular diseases, including FMD and coronary artery disease, with the putative causal noncoding variant at the rs9349379 locus acting as a potential enhancer for the endothelin-1 (EDN1) gene. Objectives: This study sought to test the association between the rs9349379 genotype and SCAD. Methods: Results from case control studies from France, United Kingdom, United States, and Australia were analyzed to test the association with SCAD risk, including age at first event, pregnancy-associated SCAD (P-SCAD), and recurrent SCAD. Results: The previously reported risk allele for FMD (rs9349379-A) was associated with a higher risk of SCAD in all studies. In a meta-analysis of 1,055 SCAD patients and 7,190 controls, the odds ratio (OR) was 1.67 (95% confidence interval [CI]: 1.50 to 1.86) per copy of rs9349379-A. In a subset of 491 SCAD patients, the OR estimate was found to be higher for the association with SCAD in patients without FMD (OR: 1.89; 95% CI: 1.53 to 2.33) than in SCAD cases with FMD (OR: 1.60; 95% CI: 1.28 to 1.99). There was no effect of genotype on age at first event, P-SCAD, or recurrence. Conclusions: The first genetic risk factor for SCAD was identified in the largest study conducted to date for this condition. This genetic link may contribute to the clinical overlap between SCAD and FMD

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.

Reduced glomerular filtration rate defines chronic kidney disease and is associated with cardiovascular and all-cause mortality. We conducted a meta-analysis of genome-wide association studies for estimated glomerular filtration rate (eGFR), combining data across 133,413 individuals with replication in up to 42,166 individuals. We identify 24 new and confirm 29 previously identified loci. Of these 53 loci, 19 associate with eGFR among individuals with diabetes. Using bioinformatics, we show that identified genes at eGFR loci are enriched for expression in kidney tissues and in pathways relevant for kidney development and transmembrane transporter activity, kidney structure, and regulation of glucose metabolism. Chromatin state mapping and DNase I hypersensitivity analyses across adult tissues demonstrate preferential mapping of associated variants to regulatory regions in kidney but not extra-renal tissues. These findings suggest that genetic determinants of eGFR are mediated largely through direct effects within the kidney and highlight important cell types and biological pathways

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Piéger des atomes avec des lasers

La découverte du refroidissement par laser de gaz dilués a permis depuis les années 1980 de s'approcher au plus prèsdu zéro absolu en température. Les gaz d'atomes froids permettent d’étudier des comportements collectifs au sein dumonde quantique, comme il en existe dans la nature par exemple pour les électrons – déterminant la conductiond’électricité ou le magnétisme. Au LPL, les atomes froids permettent de jeter un nouveau regard sur le magnétisme

Spins en interaction et systèmes analogues dans les atomes froids

This manuscript presents activities in the field of cold atoms, dealing with the realization of interacting quantum systems for the study of collective phenomena. Phenomena associated to quantum simulation of magnetism will be studied, as well as the creation of new quantum metrology technologies.We will first present experiments on Rydberg gases, interacting via the extreme polarizability of these states. We will specifically discuss excitation in electromagnetically induced transparency configuration. We will demonstrate its interest for quantum optics, and then present its application to an excitonic transport experiment. We will conclude this chapter with the analysis of an avalanche ionization, which is conducive to the creation of an ultra-cold plasma in the strong coupling regime.In a second step, we will present a quantum simulation experiment of Heisenberg magnetism, based on a degenerate gas of fermions in an optical lattice. A specificity of our system is the high spin of the particles, and a peculiar symmetry of the interaction properties. We will demonstrate that the narrow lines of the employed atom, strontium, enable a large degree of control on the spin degree of freedom of this system.Finally, we will present a new experimental activity: a superradiant laser, an "active" atomic clock where the radiation is generated by a beam of cold atoms that emit as they pass through a high finesse optical cavity. The key parameters for the design of this new device will be presented, and a theoretical development allowing to understand the main properties of this source will be introduced.Ce manuscrit présente des activités dans le domaine des atomes froids, portant sur la réalisation de systèmes quantiques composés de spins ou de dipôles en interaction. Des phénomènes du ressort de la simulation quantique du magnétisme seront étudiés, ainsi que le développement de nouvelles technologies quantiques applicables à la métrologie de fréquence.Nous présenterons tout d'abord des expériences de gaz de Rydberg, en interaction via la polarisabilité extrême de ces états. Nous discuterons spécifiquement le régime d'excitation en transparence électromagnétiquement induite. Nous en démontrerons l'intérêt pour l'optique quantique, puis nous l'appliquerons à une expérience de transport excitonique. Nous conclurons par l'analyse d'une d'ionisation en avalanche, propice à la création d'un plasma ultrafroid dans le régime de couplage fort.Dans un second temps, nous présenterons une expérience de simulation quantique du magnétisme de Heisenberg, avec un gaz dégénéré de fermions en réseau optique. La particularité de ce projet est le spin élevé des particules, et une symétrie particulière des propriétés d'interaction. Nous démontrerons l'intérêt des raies étroites de l'atome, le strontium, pour contrôler le degré de liberté de spin de ce système.Dans un dernier temps, nous introduirons une nouvelle activité expérimentale: un laser superradiant, horloge atomique "active" où le rayonnement est généré par un jet d'atomes froids émettant collectivement lors de leur traversée d'une cavité optique. Les paramètres clefs pour la conception de ce dispositif seront présentés, et un développement théorique permettant d'appréhender les principales propriétés du système sera introduit